6月22日下午，香港城市大学生物医学系教授Lee Youngjin、张汉扬到访BET356官网，在工程楼303会议室为研究生作学术报告，学院及学校相关专业的研究生参加了报告会。报告会由副院长李明主持。
Lee Youngjin做了题为《Neuron-glia energy metabolic interactions via Monocarboxylate Transporter1 (MCT1) in CNS Health and Disease》的学术报告，介绍了他在美国相关实验室的研究情况，重点阐述了MCT1基因对能量代谢调节及其与肌萎缩性侧索硬化症的发病机制，并分享了他在《NATURE》发表科研成果的心得。
张汉扬介绍了香港城市大学的历史、文化及办学理念，讲解了香港城市大学生物医学系博士招生及夏令营招生的情况。
会上，研究生与两位教授进行了深入交流。会后，Lee Youngjin和张汉扬在李明的陪同下参观了龙子湖校区。（文/杜海利）
相关链接：
Dr Youngjin Lee received his Bachelor’s and Master’s degree from the School of Pharmacy at the Sungkyunkwan University in Korea. After working a few years as a clinical pharmacist, he moved to United States for studying neuroscience at the University of Alabama at Birmingham Medical Center, and he began to do research on glial biology in the central nervous system (CNS) under the guidance of Dr Michael Brenner. After completion of his PhD thesis in 2007, he joined Jeffrey Rothstein’s lab in the school of medicine at the Johns Hopkins University for postdoctoral training in 2009, and he has investigated the role of glia in Amyotrophic Lateral Sclerosis pathogenesis before joining the Department of Biomedical Sciences at the City University of Hong Kong in 2015. During graduate- and postdoctoral- training, he significantly contributed to understanding the property and role of glia, including astroglia and oligodendroglia, in health and disease. He was a recipient of the Research Fellowship Award from the Health Fellowship Foundation in Korea (1996), and the W. Barry Wood, Jr. Research Award at the Johns Hopkins University in USA (2013). Dr Lee also was a principal investigator on Development Grant from Muscular Dystrophy Association (2011–2014).
